The overexpression of EFEMP1, HtrA1, PAM, and SDF4 in enhanced exosomes compared to naïve exosomes underscores their potential therapeutic relevance in treating ovarian dysfunction. The gene discussed is HTRA1; the disease is ovarian dysfunction.